Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Healthtrust
Covington
Merck
US Army
Mallinckrodt
McKinsey
Accenture
Deloitte

Generated: April 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 208401

« Back to Dashboard

NDA 208401 describes QBRELIS, which is a drug marketed by Silvergate Pharms and is included in one NDA. It is available from one supplier. There are three patents protecting this drug. Additional details are available on the QBRELIS profile page.

The generic ingredient in QBRELIS is lisinopril. There are twenty-one drug master file entries for this compound. Sixty-six suppliers are listed for this compound. Additional details are available on the lisinopril profile page.
Summary for 208401
Tradename:QBRELIS
Applicant:Silvergate Pharms
Ingredient:lisinopril
Patents:3
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 208401
Medical Subject Heading (MeSH) Categories for 208401
Suppliers and Packaging for NDA: 208401
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
QBRELIS lisinopril SOLUTION;ORAL 208401 NDA Silvergate Pharmaceuticals, Inc. 52652-3001 N 52652-3001-1

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;ORALStrength1MG/ML
Approval Date:Jul 29, 2016TE:RLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:Nov 6, 2035Product Flag?YSubstance Flag?Delist Request?
Patent:➤ Try a Free TrialPatent Expiration:Nov 6, 2035Product Flag?Substance Flag?Delist Request?
Patented Use:ACUTE MYOCARDIAL INFARCTION
Patent:➤ Try a Free TrialPatent Expiration:Nov 6, 2035Product Flag?Substance Flag?Delist Request?
Patented Use:METHOD OF TREATING HYPERTENSION

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Johnson and Johnson
Chinese Patent Office
Farmers Insurance
QuintilesIMS
Cantor Fitzgerald
AstraZeneca
Covington
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.